<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10962874</identifier>
<setSpec>0034-9887</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Plate, L</dc:author>
<dc:author>Araos, D</dc:author>
<dc:author>Burgos, N</dc:author>
<dc:author>Conte, G</dc:author>
<dc:author>Alfaro, J</dc:author>
<dc:author>Valdés, E</dc:author>
<dc:author>Gana, C</dc:author>
<dc:author>Von Mühlenbrock, R</dc:author>
<dc:description xml:lang="en">Acute intoxication with methotrexate, used as an abortive, has not been described in Chile. We report two female patients, aged 15 and 24 years old, who presented with mucositis, erythrodermia, pancytopenia, and elevation of hepatic enzymes. Plasma methotrexate levels confirmed the clinical diagnosis and both patients were treated with high leucovorin doses and management of associated complications. In one patient, pregnancy continued, giving birth to a newborn with cranial, face and limb malformations. The second patient had a late rescue with leucovorin and was discharged with a persistent sensory motor neuropathy. Considering the severity of complications and that patients may deny its use, when there is reasonable clinical suspicion of methotrexate intoxication, leucovorin treatment should be started.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Mar </dc:date>
<dc:title xml:lang="es">Intoxicación aguda con metotrexato usado con fines abortivos: descripción de 2 casos.</dc:title>
<dc:title xml:lang="en">[Acute poisoning with methotrexate used as an abortifacient: description of 2 cases].</dc:title>
<dc:publisher>Revista medica de Chile</dc:publisher>
</metadata>
</record>
</pubmed-document>
